JENNA COOK: Open Payments
NPI 1952773822 · ARNOLD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 89 payments from 20 companies in 2025. Trend: 2023 $1,639 · 2024 $1,993 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $440 |
| AstraZeneca Pharmaceuticals LP | 11 | $260 |
| Novo Nordisk Inc | 12 | $190 |
| Lilly USA, LLC | 4 | $108 |
| Exact Sciences Corporation | 4 | $83 |
| Amgen Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| PFIZER INC. | 3 | $43 |
Products named: VRAYLAR, QULIPTA, UBRELVY, FARXIGA, MOUNJARO, Ozempic, AIRSUPRA, Wegovy.
Industry payments across MO — which companies pay providers there.
